ConductScience.org, home

Trial · NCT03608371

Results by group85

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Area Under the Curve for UPDRS Part III During the 8 Hours of Assessment on Day 1BTRX-246040 Cohort 120224.50Standard Deviation 2301.418score on a scale*minutes
Area Under the Curve for UPDRS Part III During the 8 Hours of Assessment on Day 1BTRX-246040 Cohort 215464.33Standard Deviation 5214.729score on a scale*minutes
Area Under the Curve for UPDRS Part III During the 8 Hours of Assessment on Day 1BTRX-246040 Cohort 311682.42Standard Deviation 2231.434score on a scale*minutes
Area Under the Curve for UPDRS Part III During the 8 Hours of Assessment on Day 1Combined BTRX-24604015790.42Standard Deviation 4894.202score on a scale*minutes
Area Under the Curve for UPDRS Part III During the 8 Hours of Assessment on Day 1Placebo17547.08Standard Deviation 3110.784score on a scale*minutes
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 1Postdose Day 1 Change, 30 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 2Postdose Day 1 Change, 30 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 3Postdose Day 1 Change, 30 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)Combined BTRX-246040Postdose Day 1 Change, 30 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)PlaceboPostdose Day 1 Change, 30 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 1Postdose Day 1 Change, 60 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 2Postdose Day 1 Change, 60 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 3Postdose Day 1 Change, 60 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)Combined BTRX-246040Postdose Day 1 Change, 60 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)PlaceboPostdose Day 1 Change, 60 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 1Postdose Day 1 Change, 90 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 2Postdose Day 1 Change, 90 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)BTRX-246040 Cohort 3Postdose Day 1 Change, 90 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)Combined BTRX-246040Postdose Day 1 Change, 90 minutes postdose0.0Standard Deviation 0.00score on a scale
Change From Pre-dose Dyskinesia Rating (From the UPDRS Part III Motor Response and Dyskinesia Assessment)PlaceboPostdose Day 1 Change, 90 minutes postdose0.0Standard Deviation 0.00score on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03608371/results?page=2